Você procurou por: hypertension (Italiano - Alemão)

and ocular hypertension
and ocular hypertension

c09ca0 treatment of hypertension
c09ca0 behandlung von bluthochdruck

c09da treatment of essential hypertension
c09da behandlung von bluthochdruck

boehringer ingelheim international gmbh treatment of de hypertension
boehringer ingelheim international gmbh d

ipertensione arteriosa polmonare (pulmonary arterial hypertension, pah)
pulmonal arterielle hypertonie (pah)

treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
points to consider on validity and interpretation of meta-analyses, and one pivotal study zur stellungnahme freigegeben im oktober 2000

c09da treatment of essential hypertension in patients whose blood pressure is
c09da treatment of essential hypertension in patients whose blood pressure is not adequately controlled on telmisartan alone

certi tipi di ipertensione arteriosa polmonare (pulmonary arterial hypertension pah)
bestimmte formen der pulmonal arteriellen hypertonie (pah).

ipertensione polmonare tromboembolica cronica (chronic thromboembolic pulmonary hypertension cteph)
chronisch thromboembolische pulmonale hypertonie (cteph).

sanofi pharma c09da bristol-myers treatment of squibb snc essential hypertension fr
bristol-myers squibb pharma eeig f

in un sottogruppo di pazienti nello studio griphon la qualità della vita è stata valutata utilizzando il questionario camphor (cambridge pulmonary hypertension outcome review).
bei einer subgruppe von patienten der griphon-studie wurde die lebensqualität mittels des camphor-fragebogens (cambridge pulmonary hypertension outcome review) erfasst.

volibris è indicato, da solo o in associazione con altri medicinali, per il trattamento di adulti con ipertensione polmonare arteriosa (pulmonary arterial hypertension, pah).
volibris wird allein oder in kombination mit anderen arzneimitteln zur behandlung von erwachsenen mit pulmonaler arterieller hypertonie (pah) angewendet.

treatment of primary and of the following forms of secondary pulmonary hypertension: connective tissue disease pulmonary hypertension, drug-induced pulmonary hypertension, portopulmonary hypertension, pulmonary hypertension associated with congenital heart disease and chronic thromboembolic pulmonary hypertension
note for guidance on the clinical investigation of recombinant factor viii and ix products verabschiedet im oktober 2000